Using a Mounjaro weight loss calculator: what the numbers actually mean

Mounjaro (tirzepatide) is the only dual GIP and GLP-1 receptor agonist licensed in the UK for weight management, activating two appetite-regulating pathways rather than one.
The SURMOUNT-1 trial ran for 72 weeks with 2,539 adults; average weight loss at 15mg was around 20–21%, but individual results varied widely across the group.
Any weight estimate based on trial averages is illustrative only, your dose, diet, activity level and individual biology all shift the outcome.
Tirzepatide is a Prescription-Only Medicine: a GPhC-registered Independent Prescriber must assess your suitability before treatment can be dispensed.

There is no single validated Mounjaro weight loss calculator, but trial data gives us a clear picture: in the SURMOUNT-1 study, adults taking tirzepatide lost an average of around 20–21% of their body weight over 72 weeks at the highest dose. Knowing your starting weight, you can apply those percentages yourself — but the number you land on is a population average, not a personal forecast. These are prescription-only medicines, and a prescriber will assess whether treatment is right for you based on far more than one figure. What a tirzepatide calculator online can do is give you a sensible range to think about before your consultation — it cannot predict your individual result, and it cannot replace clinical review.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

How to think through your weight loss estimate on Mounjaro, and when to stop doing the maths alone

What an online weight loss calculator for Mounjaro can and cannot tell you

Several unofficial calculators circulate online (some labelled as a "Mounjaro calculator" or a "tirzepatide calculator for weight loss") and most follow the same logic: enter your current weight, choose a percentage drawn from SURMOUNT-1, and get a target weight. That maths is straightforward enough. If you weigh 100kg and lose 20%, you end up at 80kg. Useful as a rough orientation? Yes. Reliable as a personal prediction? No.

The SURMOUNT-1 figures come from a tightly controlled 72-week trial with specific inclusion criteria, structured diet support and regular clinical oversight, conditions that do not map perfectly onto everyday life. Within the trial itself, outcomes ranged considerably; some participants lost more, some less. The average tells you what a large group achieved, not what you will achieve.

There is also a dose dimension that simple calculators tend to flatten. Tirzepatide starts at 2.5mg (a dose designed to help your body adjust, not to drive significant weight loss) and titrates upward, typically in four-week steps, as your prescriber judges appropriate. The strongest results in the trials came at 10mg and 15mg. Reaching those doses takes months, and not everyone does. A calculator that applies the 15mg trial average to week one gives you a number that feels compelling but has no clinical basis behind it. If you want to go deeper before drawing conclusions from any estimate, our tirzepatide ratio calculator is one place to explore the numbers more carefully alongside a fuller explanation of what they mean. You can also read more about the full picture of how tirzepatide works before drawing conclusions from any estimate.

The real decision: what factors shape your individual result

If you are weighing up whether Mounjaro is likely to help you, the honest answer is that the variables are genuinely personal. Starting weight matters, people with higher baseline BMIs tend to lose more absolute kilograms, though percentage losses can look similar across the range. Whether you also have type 2 diabetes matters: SURMOUNT-1 specifically enrolled adults without diabetes, and weight loss in trials that included people with diabetes was somewhat lower. Your starting dose, how quickly you titrate, how well you tolerate each step, your dietary changes alongside treatment, your activity level, all of these move the dial.

There is also the question of how your body individually responds to reduced appetite. Many people find the medicines significantly easier to tolerate than they expected; others find GI side effects slow their titration. That is not a failure, it is the prescriber's job to manage it. The clinical detail on Mounjaro covers side effects and the titration schedule in full if you want to read ahead.

One thing worth acknowledging honestly: if you are here running numbers at whatever time it is, you have probably been trying to figure out whether this is worth doing, whether it will actually work for you specifically, and whether the cost makes sense. That is a reasonable place to be. A calculator gives you a rough signal. The consultation gives you a real answer.

How NHS eligibility criteria change the calculation

NICE recommends tirzepatide for adults with a BMI of 35 or above plus at least one weight-related condition such as high blood pressure, dyslipidaemia, obstructive sleep apnoea, cardiovascular disease or type 2 diabetes. NHS access is also being phased in by cohort, as of June 2026, the current cohort covers a BMI of 35–39.9 with four or more of those conditions. Lower BMI thresholds apply for some ethnic backgrounds under UK guidance. You can check what the licensed eligibility criteria look like in plain terms if you are unsure where you sit.

Privately, the licensed threshold is lower: adults with a BMI of 30 or above, or 27 or above with at least one weight-related condition, can be considered. This is the route most people using a Mounjaro weight loss calculator are exploring, because they do not meet NHS criteria or prefer not to wait. The key point is that the BMI threshold is the floor, not the whole story. A prescriber assesses your health picture in full, our clinical team brings that same rigour to every consultation, including checking ID, verifying your weight live and reviewing your medical history. The cost of Mounjaro privately covers all of that in a single transparent price, with no separate consultation or prescription fee added later.

If you have questions before you start, the frequently asked questions section covers common queries, and you can reach our aftercare team seven days a week. For anything specific to your situation (including whether a GI medicine like loperamide is safe to take alongside treatment) a prescriber is the right person to ask, and our page on taking Imodium on Mounjaro walks through that question in detail.

Putting the estimate in its proper place

The NICE technology appraisal for tirzepatide (TA1026) is built on the same SURMOUNT trial data any online calculator draws from. The difference is that NICE's appraisal also accounts for clinical heterogeneity, the range of real-world results across different patients. That is why recommendations come with monitoring criteria: if less than 5% of body weight is lost after six months at the highest tolerated dose, continuing treatment is reviewed. The expectation is not that everyone hits the headline figure. It is that treatment is proportionate to individual benefit.

A Mounjaro calculator can be a useful first step in framing your expectations. Use it to get a rough range, not a target. Then bring that curiosity into a consultation, where a prescriber can tell you whether tirzepatide is appropriate for you and what realistic progress might look like given your specific circumstances. That conversation is free at nume, takes place the same day, and is reviewed by a real clinician, not routed through software.

When you are ready, speak to our prescribers through a free consultation.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions